Latest News about MRNA
Recent news which mentions MRNA
Individualized Cancer Treatment: Merck/Moderna's Personalized Skin Cancer Therapy Enters Late-Stage Of Development
July 26, 2023
From Benzinga
Moderna On Cathie Wood's Radar Ahead Of Q2 Results: Ark Boosts Stake In COVID-19 Vaccine Maker By $12M This Week
July 26, 2023
From Benzinga
Cathie Wood's Ark Invest Makes Major Moves In This Warren Buffett-Backed EV Company, Moderna
July 24, 2023
From Benzinga
From InvestorPlace
Fentanyl Crisis In US: Biden Administration Contemplates Easing Sanctions on China's Forensic Institute
July 24, 2023
From Benzinga
From Benzinga
Analyst Initiates Arcturus: Sees Attractive Growth Trajectory with Vaccine Franchise Despite Competition
July 24, 2023
From Benzinga
Moderna Is Fairly Valued, Balancing Declining COVID-19 Base Business with Promising Future Pipeline: Analyst
July 24, 2023
From Benzinga
From Benzinga
Obey the Sell Signals: 3 Blue-Chip Stocks to Let Go
July 20, 2023
From InvestorPlace
From Benzinga
From Motley Fool
Tickers
MRNA
From Motley Fool
From Benzinga
From InvestorPlace
7 Biotech Stocks to Sell in July
July 13, 2023
From InvestorPlace
From Motley Fool
EXCLUSIVE: The 20 Most-Searched For Tickers On Benzinga Pro From The First Six Months Of 2023
July 11, 2023
From Benzinga
What's Going On With Novavax (NVAX) Stock?
July 10, 2023
From Benzinga
Tesla, Netflix And 2 Other Stocks Insiders Are Selling
July 10, 2023
From Benzinga
From Motley Fool
A Big Test Is Looming for Pfizer, Moderna, and Novavax
July 06, 2023
From Motley Fool
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.